Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Jan 19, 2023
Date Accepted: Mar 16, 2023

The final, peer-reviewed published version of this preprint can be found here:

mHealth to Improve Experience, Adherence to Pharmacological Treatment, and Positive Mental Health in Patients Diagnosed With Femur Fractures: Protocol for a Quasi-Experimental Study

Marcos G

mHealth to Improve Experience, Adherence to Pharmacological Treatment, and Positive Mental Health in Patients Diagnosed With Femur Fractures: Protocol for a Quasi-Experimental Study

JMIR Res Protoc 2023;12:e45856

DOI: 10.2196/45856

PMID: 37115614

PMCID: 10182452

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

mHealth to improve experience, adherence to pharmacological treatment and positive mental health in patients diagnosed with femur fractures: protocol for a quasi-experimental study

  • Gemma Marcos

ABSTRACT

Background:

Considering the prognosis of femur fractures worldwide, the ageing of our society, and the problems in adherence to treatment found in these patients, it is believed that mHealth can have a positive impact on the process and quality of care.

Objective:

We aim to evaluate the effectiveness of a pharmacological educational nurse intervention with Myplan App with regards to knowledge, adherence to pharmacological treatment and positive mental health of patients with a femur fracture.

Methods:

A non-randomized, quasi-experimental study will be carried out with a Pretest-Posttest control group. It will include 278 elderly patients diagnosed with femur fracture and a GCS of 15, with access to mobile devices. Patients with psychological pathologies, cognitive impairment or treated in isolation will be excluded. Study variables; sociodemographic (adhoc form), patient experience (Patient Experience Questionnaire-15), adherence to pharmacological treatment (Morisky-Green questionnaire), positive mental health (Positive Mental Health questionnaire). The measurements will be taken 24 hours after admission, upon discharge, and 25 days after discharge.

Results:

Enrollment was initiated in October 2022 and will be completed in April 2023. The main contribution of this protocol is a detailed description of a nursing intervention with the support of a smartphone app that will generate knowledge about patients’ experience, their adherence, and their positive mental health.

Conclusions:

The results of this study will offer evidence of the effectiveness of a pharmacological educational nurse intervention by means of a free smartphone app. If its efficacy is demonstrated and the results are acceptable, it could mean an improvement in the care of patients with femur fractures and this technology could be used to guide other training interventions in patients with other pathologies. Clinical Trial: The protocol is registered in IRRID: NCTT05669040.


 Citation

Please cite as:

Marcos G

mHealth to Improve Experience, Adherence to Pharmacological Treatment, and Positive Mental Health in Patients Diagnosed With Femur Fractures: Protocol for a Quasi-Experimental Study

JMIR Res Protoc 2023;12:e45856

DOI: 10.2196/45856

PMID: 37115614

PMCID: 10182452

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.